.NET Developer Sai Nitisha Tadiboina Makes Strides in AI-based Prevention of Diabetes and Pancreatic Cancer
The artificial intelligence expert uses a deep learning algorithm to develop an early detection and prevention system.
New York City, NY, 19th September 2023, ZEX PR WIRE,Machines permeate every sphere of the healthcare sector, save one: Prevention. When diseases are identified before they have the chance to display symptoms, their chances of progressing decrease exponentially. Visionary in the current climate, this goal is what Sai Nitisha Tadiboina sought to realize with Patent: 202241076373.
Even though screening techniques exist for screening people at high risk of diabetes and pancreatic cancer, there are no acute and objective methods for early detection. Deductive methods seldom work with diseases sharing multiple symptoms. A better technique is required to predict pancreatic cancer risk; this is where Tadiboina’s Artificial Neural Network comes in.
“The ANN is without a doubt better than any AI tool for detecting cancer risk that we have today,” stated a source close to Tadiboina. “It was created after studying the health records of hundreds of thousands of candidates on the Health Interview Survey and Pancreatic, Lung, Colorectal, and Ovarian Cancer databases. The data was used to design, train, and test the ANN. The algorithm is 87.3% sensitive and 80% specific during the screenings. It’s anything but a baby step in the grand scheme of diseases with poor prognoses.”
Indeed, only one percent of patients with advanced-stage pancreatic cancer can survive five years. On the other hand, diabetes ranks among the top ten causes of death in the US. Tadiboina sees early detection as the only way of beating these illnesses. The artificial intelligence researcher has worked tirelessly to propose lifesaving interventions in the healthcare field.
Apart from diabetes and pancreatic cancer, Tadiboina has researched AI-based methods for detecting and treating breast cancer in women and men. Her treatment research focuses on developing personalized methods based on patient-related accounts. On the other hand, detection methods focus on early, less invasive, and more accurate methods of identifying carcinomas.
Share insights with the AI expert. Connect with her on LinkedIn.
About Sai Nitisha Tadiboina
Sai Nitisha Tadiboina is a mentor, keynote speaker, and researcher in artificial intelligence, specifically machine learning. Her research focuses on the applications and uses of AI in healthcare and has recently expanded to cancer research. Connect with the AI expert for more insights and collaborations.
ZEX PR Wire offers massive Press Release, News, Authored Articles, Editorial services, geared at generating massive exposure for your unique project, business, or concept.
ZEX PR WIRE is a premium press release distribution provides end-to- end solutions to produce, optimize and target content and then distribute and measure results. Combining the world's largest multi-channel, multi-cultural content distribution and optimization network with comprehensive workflow tools and platforms, ZEX PR WIRE serves tens of thousands of clients from offices in the Americas, Europe, Middle East, Africa and Asia-Pacific regions.
Disclaimer: ZEXPRWIRE is a newswire distribution network. Articles and other content published by ZEXPRWIRE are the legal responsibility of the author and ZEXPRWIRE accepts no liability for the content of such material. ZEXPRWIRE publishes content for informational purposes and makes no representations regarding, recommendation or invitation to engage in, any form of financial or investment activity, and does not endorse the content of any material published.
ZEX PR WIRE allows users to submit their press releases through our online platform. Once submitted, our team reviews the content for quality and relevance. Upon approval, the press release is distributed to our extensive network, including major news outlets, industry-specific publications, and online platforms.
You can streamline the distribution process while still benefiting from human oversight. This ensures that your press releases meet quality standards, increasing the likelihood of media coverage and enhancing your brand's visibility.
ZEX PR WIRE accepts a wide range of press releases, including product launches, company announcements, event promotions, new partnerships, industry insights, and more. However, we do not accept press releases containing offensive or illegal content. For more information on this please visit https://zexprwire.com/editorial-guidelines/
Pricing for using ZEX PR WIRE varies depending on the distribution package you choose. We offer different plans to suit various needs and budgets. For detailed pricing information, please visit https://pr.zexprwire.com/pricing
You can view the total number of site submissions, status for each submission (live/pending), hyperlinks for each live PR, details pertaining to your package and number of press releases remaining, and view count for each live PR through third-party tracker integrations. (You may change the content according to what we provide in analytics).
ZEX PR Wire operates between 10AM to 7PM IST. During these hours, press releases may be distributed immediately after editorial approval of the press release. Otherwise, it will be published the next day. Additionally, several publications might require more than one day to be completed.
It generally takes 24- 72 hrs to publish the press release and generate the report
Yes, ZEX PR WIRE allows you to schedule the distribution of your press release for a specific date and time. This feature enables you to plan your PR campaigns strategically and ensure that your news reaches the right audience at the right time.
If you have any further questions or need assistance, you can reach out to our customer support team through direct Whatsapp ,chat on the web or can write to us at [email protected]. We are available to help you with any queries or concerns you may have.